166 related articles for article (PubMed ID: 19876923)
1. A gastrin precursor, gastrin-gly, upregulates VEGF expression in colonic epithelial cells through an HIF-1-independent mechanism.
Bertrand C; Kowalski-Chauvel A; Do C; Résa C; Najib S; Daulhac L; Wang TC; Ferrand A; Seva C
Int J Cancer; 2010 Jun; 126(12):2847-57. PubMed ID: 19876923
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
Sun YZ; Cai N; Liu NN
Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
[TBL] [Abstract][Full Text] [Related]
3. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.
Chetty C; Lakka SS; Bhoopathi P; Rao JS
Int J Cancer; 2010 Sep; 127(5):1081-95. PubMed ID: 20027628
[TBL] [Abstract][Full Text] [Related]
4. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization.
Yang XM; Wang YS; Zhang J; Li Y; Xu JF; Zhu J; Zhao W; Chu DK; Wiedemann P
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1873-9. PubMed ID: 19098317
[TBL] [Abstract][Full Text] [Related]
5. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
[TBL] [Abstract][Full Text] [Related]
6. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
Zhong XS; Zheng JZ; Reed E; Jiang BH
Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
[TBL] [Abstract][Full Text] [Related]
7. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
8. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA
Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804
[TBL] [Abstract][Full Text] [Related]
9. GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction.
Huang SM; Chen TS; Chiu CM; Chang LK; Liao KF; Tan HM; Yeh WL; Chang GR; Wang MY; Lu DY
Endocr Relat Cancer; 2014 Feb; 21(1):73-84. PubMed ID: 24165321
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
Tammali R; Saxena A; Srivastava SK; Ramana KV
J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240
[TBL] [Abstract][Full Text] [Related]
11. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition.
Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J
J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463
[TBL] [Abstract][Full Text] [Related]
12. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
13. UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway.
Li Y; Bi Z; Yan B; Wan Y
Int J Mol Med; 2006 Oct; 18(4):713-9. PubMed ID: 16964427
[TBL] [Abstract][Full Text] [Related]
14. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
Gabellini C; De Luca T; Trisciuoglio D; Desideri M; Di Martile M; Passeri D; Candiloro A; Biffoni M; Rizzo MG; Orlandi A; Del Bufalo D
Carcinogenesis; 2013 Nov; 34(11):2558-67. PubMed ID: 23836782
[TBL] [Abstract][Full Text] [Related]
15. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
16. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
17. Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner.
Jo JO; Kim SR; Bae MK; Kang YJ; Ock MS; Kleinman HK; Cha HJ
Biochim Biophys Acta; 2010 Nov; 1803(11):1244-51. PubMed ID: 20691219
[TBL] [Abstract][Full Text] [Related]
18. Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma.
Kobayashi I; Semba S; Matsuda Y; Kuroda Y; Yokozaki H
Pathobiology; 2006; 73(1):8-17. PubMed ID: 16785763
[TBL] [Abstract][Full Text] [Related]
19. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.
Tang X; Zhang Q; Shi S; Yen Y; Li X; Zhang Y; Zhou K; Le AD
Int J Cancer; 2010 Jan; 126(1):90-103. PubMed ID: 19569175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
